A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 52,177 shares of PFE stock, worth $1.39 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
52,177
Previous 51,379 1.55%
Holding current value
$1.39 Million
Previous $1.44 Million 5.08%
% of portfolio
0.06%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $22,104 - $25,049
798 Added 1.55%
52,177 $1.51 Million
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $113,619 - $133,140
-4,498 Reduced 8.05%
51,379 $1.44 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $403,702 - $463,579
15,593 Added 38.71%
55,877 $1.55 Million
Q4 2023

Jan 30, 2024

SELL
$26.13 - $33.94 $53,749 - $69,814
-2,057 Reduced 4.86%
40,284 $1.16 Million
Q3 2023

Oct 17, 2023

BUY
$32.09 - $37.51 $108,047 - $126,296
3,367 Added 8.64%
42,341 $1.4 Million
Q2 2023

Jul 19, 2023

SELL
$36.12 - $41.79 $109,082 - $126,205
-3,020 Reduced 7.19%
38,974 $1.43 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $385,076 - $501,313
9,776 Added 30.34%
41,994 $1.71 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $136,230 - $177,833
-3,263 Reduced 9.2%
32,218 $1.65 Million
Q3 2022

Oct 26, 2022

BUY
$43.76 - $53.42 $48,529 - $59,242
1,109 Added 3.23%
35,481 $1.55 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $6,235 - $7,392
-134 Reduced 0.39%
34,372 $1.8 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $34,998 - $43,367
765 Added 2.27%
34,506 $1.79 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $77,764 - $115,272
1,882 Added 5.91%
33,741 $1.99 Million
Q3 2021

Nov 02, 2021

SELL
$39.25 - $50.42 $17,584 - $22,588
-448 Reduced 1.39%
31,859 $1.37 Million
Q2 2021

Jul 27, 2021

BUY
$35.91 - $40.68 $6,499 - $7,363
181 Added 0.56%
32,307 $1.27 Million
Q1 2021

May 11, 2021

SELL
$33.49 - $37.77 $1 Million - $1.13 Million
-29,964 Reduced 48.26%
32,126 $1.16 Million
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $204,669 - $260,254
6,115 Added 10.92%
62,090 $2.29 Million
Q3 2020

Oct 20, 2020

BUY
$31.75 - $37.25 $142,621 - $167,327
4,492 Added 8.73%
55,975 $2.05 Million
Q2 2020

Jul 02, 2020

BUY
$30.12 - $36.54 $9,548 - $11,583
317 Added 0.62%
51,483 $1.6 Million
Q1 2020

Apr 01, 2020

SELL
$27.03 - $38.62 $20,029 - $28,617
-741 Reduced 1.43%
51,166 $1.58 Million
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $46,581 - $52,864
1,415 Added 2.8%
51,907 $1.93 Million
Q3 2019

Oct 09, 2019

SELL
$32.49 - $42.13 $465,549 - $603,680
-14,329 Reduced 22.11%
50,492 $1.72 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $211,784 - $237,785
5,727 Added 9.69%
64,821 $2.81 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $26,025 - $28,592
694 Added 1.19%
59,094 $2.49 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $13,849 - $15,789
-360 Reduced 0.61%
58,400 $2.52 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $7,514 - $9,114
-218 Reduced 0.37%
58,760 $2.56 Million
Q2 2018

Aug 16, 2018

SELL
$32.98 - $35.16 $102,435 - $109,206
-3,106 Reduced 5.0%
58,978 $2.14 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $43,525 - $50,495
-1,364 Reduced 2.15%
62,084 $2.2 Million
Q4 2017

Feb 08, 2018

BUY
$33.26 - $35.29 $603,170 - $639,984
18,135 Added 40.02%
63,448 $2.3 Million
Q3 2017

Nov 08, 2017

SELL
$31.0 - $34.15 $247,349 - $272,482
-7,979 Reduced 14.97%
45,313 $1.94 Million
Q2 2017

Aug 15, 2017

BUY
N/A
53,292
53,292 $1.79 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.